<DOC>
	<DOCNO>NCT02552888</DOCNO>
	<brief_summary>The propose randomized control trial test safety efficacy combination therapy sodium nitrite isoquercetin endothelial function inflammation among patient chronic kidney disease .</brief_summary>
	<brief_title>Nitrite , Isoquercetin Endothelial Dysfunction ( NICE ) Trial</brief_title>
	<detailed_description>The propose randomized control trial test safety efficacy combination therapy sodium nitrite isoquercetin endothelial function inflammation among patient chronic kidney disease . Investigators recruit 70 albuminuric CKD patient randomly assign participant combination therapy sodium nitrite isoquercetin placebo three month .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Men woman age 2174 year old race/ethnicity background CKD define eGFR &lt; 60 ml/min/1.73 m2 urinary albumin creatinine ratio ≥ 30 mg/g protein creatinine ratio ≥150 mg/g . Systolic BP≥120 &lt; 180 mmHg and/or diastolic BP≥70 &lt; 110 mmHg Allergic organic nitrite , isoquercetin , niacin , vitamin C Institutionalized ( e.g. , prisoner , nursing home skilled nursing facility resident ) Unable unwilling give consent Known HIV infection and/or AIDS Pregnant lactate woman Currently dialysis Previous current organ bone marrow transplant Receiving immunosuppressive treatment immunotherapy Receiving chemotherapy alkylating agent systemic cancer Recent acute myocardial infarction , cerebrovascular accidence transient ischemic attack , hospitalization 3 month Acute kidney injury within previous 3 month Currently take phosphodiesterase5 enzyme inhibitor , Viagra History chronic headache Chronically receive fluoroguinolones , cyclosporin ( neural , sandimmune ) , nitrate drug , NSAIDS ( except aspirin ≤ 81 mg daily ) , allopurinol uloric , meperidine related central nervous system ( CNS ) depressant , oral glucocorticoid , willing able stop study period . Active infection ( i.e . systemic osteomyelitis ) Class III IV heart failure History hemolytic anemia include sickle cell disease Hemoglobin &lt; 10 History chronic obstructive pulmonary disease ( COPD ) Have positive screen glucose6phosphate dehydrogenase ( G6PD ) deficiency screen Involvement clinical trial Current alcohol substance abuse Current smoker Unwillingness stop flavonoid supplementation Unwillingness stop nitrate and/or nitrite supplementation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Endothelial Dysfunction</keyword>
	<keyword>Inflammation</keyword>
</DOC>